Mun-Gavin David C. 4
4 · GT Biopharma, Inc. · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Mun-Gavin David C.
Director
Transactions
- Award
Option to purchase Common Stock
2025-09-04+31,250→ 31,250 totalExercise: $1.33Exp: 2035-08-19→ Common Stock (31,250 underlying)
Footnotes (1)
- [F1]The options are fully vested and exercisable.